Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes

August 17, 2019 updated by: Romeu Duarte Carneiro Mendes, University of Trás-os-Montes and Alto Douro

Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes: Effects on Health and Well-being

Type 2 diabetes is a chronic disease that affects approximately 13% of Portuguese population and is associated with a high cardiovascular mortality by coronary artery disease and cerebrovascular disease and with a serious decline on well-being. Lifestyle changes are widely recommended to the control of type 2 diabetes and its complications. This study aims to analyse the effects of different community-based lifestyle programs (exercise or exercise plus dietary intervention) on health and well-being in patients with type 2 diabetes.

Study Overview

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vila Real, Portugal, 5000-801
        • University of Trás-os-Montes e Alto Douro

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients with diagnosed type 2 diabetes at least for six months;
  2. Both genders;
  3. Aged between 50 and 80 years old;
  4. Non-smokers;
  5. Not engaged in supervised exercise;
  6. Community-dwelling;
  7. Medical recommendation for lifestyle intervention;
  8. Known medical history;
  9. Diabetes complications under medical control (poor metabolic control, diabetic foot, diabetic retinopathy, diabetic nephropathy and diabetic autonomic neuropathy;
  10. No cardiovascular, respiratory and musculoskeletal contraindications to exercise;
  11. No gait and balance problems;
  12. Not taking insulin or sulfonylureas for less than three months;
  13. Volunteer participation with signed informed consent.

Exclusion Criteria:

  1. Participation in another supervised exercise program during the study;
  2. Participation in another supervised dietary intervention during the study;
  3. Aggravation of a diabetes complication or another major health problem;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Community-based exercise program
Community-based exercise program with 3 weekly exercise sessions
Experimental: Exercise plus dietary intervention
Community-based exercise and dietary intervention program
Community-based exercise program with 3 weekly exercise sessions
Community-based dietary intervention program
No Intervention: Control
Habitual physical activity and habitual dietary pattern

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiovascular Risk
Time Frame: Baseline, 9 and 21 months
UKPDS Risk Engine
Baseline, 9 and 21 months
Health-Related Quality of Life
Time Frame: Baseline, 9 and 21 months
SF-36 Health Survey
Baseline, 9 and 21 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food Literacy
Time Frame: Baseline, 9 and 21 months
General Nutrition Knowledge Questionnaire for Adults
Baseline, 9 and 21 months
Dietary Pattern
Time Frame: Baseline, 9 and 21 months
3-day Food Record
Baseline, 9 and 21 months
Physical Fitness
Time Frame: Baseline, 9 and 21 months
Physical Fitness Test Battery
Baseline, 9 and 21 months
Diabetic Foot Risk
Time Frame: Baseline, 9 and 21 months
International Working Group on the Diabetic Foot Risk Classification)
Baseline, 9 and 21 months
Exercise-Related Adverse Events
Time Frame: Baseline, 9 and 21 months
Number of acute injuries or adverse events during exercise sessions
Baseline, 9 and 21 months
Systolic Blood Pressure
Time Frame: Baseline, 9 and 21 months
mmHg
Baseline, 9 and 21 months
Diastolic Blood Pressure
Time Frame: Baseline, 9 and 21 months
mmHg
Baseline, 9 and 21 months
Glycemic Control
Time Frame: Baseline, 9 and 21 months
Glycated Hemoglobin
Baseline, 9 and 21 months
Fast blood glucose
Time Frame: Baseline, 9 and 21 months
mg/dL
Baseline, 9 and 21 months
Total Cholesterol
Time Frame: Baseline, 9 and 21 months
mg/dL
Baseline, 9 and 21 months
Body Fat Mass
Time Frame: Baseline, 9 and 21 months
Bioelectrical impedance analysis
Baseline, 9 and 21 months
Body Lean Mass
Time Frame: Baseline, 9 and 21 months
Bioelectrical impedance analysis
Baseline, 9 and 21 months
Quality of Sleep
Time Frame: Baseline, 9 and 21 months
Pittsburgh Sleep Quality Index
Baseline, 9 and 21 months
Symptoms of Anxiety and Depression
Time Frame: Baseline, 9 and 21 months
Hospital Anxiety and Depression Scale
Baseline, 9 and 21 months
Chronic Pain
Time Frame: Baseline, 9 and 21 months
Brief Pain Inventory Questionnaire
Baseline, 9 and 21 months
Diabetes-Dependent Quality of Life
Time Frame: Baseline, 9 and 21 months
Audit of Diabetes-Dependent Quality of Life Questionnaire
Baseline, 9 and 21 months
Habitual Physical Activity
Time Frame: Baseline, 9 and 21 months
International Physical Activity Questionnaire
Baseline, 9 and 21 months
Waist Circumference
Time Frame: Baseline, 9 and 21 months
cm
Baseline, 9 and 21 months
Falls Risk
Time Frame: Baseline, 9 and 21 months
Timed Up and Go Test
Baseline, 9 and 21 months
Sitting-Time
Time Frame: Baseline, 9 and 21 months
Hours per day
Baseline, 9 and 21 months
Energy Expenditure
Time Frame: Baseline, 9 and 21 months
kcal/kg/min
Baseline, 9 and 21 months
Body Mass Index
Time Frame: Baseline, 9 and 21 months
kg/m2
Baseline, 9 and 21 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Romeu Mendes, MD PhD, University of Trás-os-Montes e Alto Douro

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

October 11, 2015

First Submitted That Met QC Criteria

December 13, 2015

First Posted (Estimate)

December 16, 2015

Study Record Updates

Last Update Posted (Actual)

August 20, 2019

Last Update Submitted That Met QC Criteria

August 17, 2019

Last Verified

August 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on Exercise

Subscribe